These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31148582)

  • 1. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.
    Yang JR; Xu JY; Chen GC; Yu N; Yang J; Zeng DX; Gu MJ; Li DP; Zhang YS; Qin LQ
    Sci Rep; 2019 May; 9(1):8143. PubMed ID: 31148582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
    Koh YW; Lee HW
    Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
    Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
    J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
    [No Abstract]   [Full Text] [Related]  

  • 5. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
    Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer.
    Ran H; Ma J; Cai L; Zhou H; Yuan Z; Chen Y; Chang W; Huang Y; Xiao Y
    BMC Cancer; 2022 Jan; 22(1):93. PubMed ID: 35062903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.
    Miyamoto T; Fujitani M; Fukuyama H; Hatanaka S; Koizumi Y; Kawabata A
    J Palliat Med; 2019 May; 22(5):532-537. PubMed ID: 30570426
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic Impact of Postoperative C-reactive Protein for Non-small Cell Lung Cancer Following Lobectomy.
    Shinohara S; Sugaya M; Onitsuka T; Machida K; Matsuo M; Tanaka F
    Anticancer Res; 2018 May; 38(5):3193-3198. PubMed ID: 29715162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer.
    Zhou S; Jiang W; Wang H; Wei N; Yu Q
    Cancer Med; 2020 Sep; 9(17):6268-6280. PubMed ID: 32691996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival innon-small-cell lung cancer.
    Bacha S; Sghaier A; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Zaouri B; Chabbou A
    Tunis Med; 2017 Dec; 95(12):229-235. PubMed ID: 29878284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer.
    Xiao X; Wang S; Long G
    Medicine (Baltimore); 2019 Jun; 98(26):e16238. PubMed ID: 31261584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
    Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
    Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer].
    Xu Y; Li Z; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):400-3. PubMed ID: 21569644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of C-reactive protein/albumin ratio and its relationship with survival in dogs with acute pancreatitis.
    Gori E; Pierini A; Lippi I; Ceccherini G; Perondi F; Marchetti V
    N Z Vet J; 2020 Nov; 68(6):345-348. PubMed ID: 32539626
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.
    Richlitzki C; Wiesweg M; Metzenmacher M; Guberina N; Pöttgen C; Hautzel H; Eberhardt WEE; Darwiche K; Theegarten D; Aigner C; Bölükbas S; Schuler M; Stuschke M; Guberina M
    Sci Rep; 2024 Jun; 14(1):13765. PubMed ID: 38877146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.